Avalo Therapeutics (AVTX)
(Delayed Data from NSDQ)
$15.94 USD
+0.96 (6.41%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $15.37 -0.57 (-3.58%) 7:58 PM ET
1-Strong Buy of 5 1
F Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | -1.18 |
EPS Last Quarter | NA |
Last EPS Surprise | NA |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.91 |
Next Year | -0.97 |
EPS (TTM) | -616.67 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.48M | 0.64M | 1.92M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.18 | -0.19 | -0.91 | -0.97 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -1.18 | -0.19 | -0.91 | -0.97 |
Low Estimate | -1.18 | -0.19 | -0.91 | -0.97 |
Year ago EPS | -202.38 | -140.48 | -114.00 | -0.91 |
Year over Year Growth Est. | 99.42% | 99.86% | 99.20% | -6.59% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.18 | -0.19 | -0.91 | -0.97 |
7 Days Ago | -1.18 | -0.19 | -0.91 | -0.97 |
30 Days Ago | -4.76 | -4.76 | -16.67 | -16.67 |
60 Days Ago | -4.76 | -4.76 | -16.67 | -16.67 |
90 Days Ago | -4.76 | -4.76 | -16.67 | -16.67 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.18 | -0.19 | -0.91 | -0.97 |
Zacks Consensus Estimate | -1.18 | -0.19 | -0.91 | -0.97 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | NA | -26.19 | -140.48 | -202.38 | NA |
Estimate | NA | -261.90 | -214.29 | -230.95 | NA |
Difference | NA | 235.71 | 73.81 | 28.57 | 112.70 |
Surprise | NA | 90.00% | 34.44% | 12.37% | 45.60% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more